FORD MOTOR CO — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that FORD MOTOR CO filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $184.99B | Feb 6, 2025 |
| FY2024 | Dec 31, 2023 | $176.19B | Feb 6, 2025 |
| FY2024 | Dec 31, 2022 | $158.06B | Feb 6, 2025 |
| FY2023 | Dec 31, 2021 | $136.34B | Feb 7, 2024 |
| FY2020 | Dec 31, 2020 | $35.95B | Feb 5, 2021 |
| FY2020 | Sep 30, 2020 | $37.50B | Feb 5, 2021 |
| FY2020 | Jun 30, 2020 | $19.37B | Feb 5, 2021 |
| FY2020 | Mar 31, 2020 | $34.32B | Feb 5, 2021 |
| FY2020 | Dec 31, 2019 | $39.72B | Feb 5, 2021 |
| FY2020 | Sep 30, 2019 | $36.99B | Feb 5, 2021 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $187.27B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $184.99B | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $176.19B | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $158.06B | Feb 6, 2025 |
| FY2023 | Dec 31, 2021 | $136.34B | Feb 7, 2024 |
| FY2022 | Dec 31, 2020 | $127.14B | Feb 3, 2023 |
| FY2021 | Dec 31, 2019 | $155.90B | Feb 4, 2022 |
| FY2020 | Dec 31, 2018 | $160.34B | Feb 5, 2021 |
| FY2019 | Dec 31, 2017 | $156.78B | Feb 5, 2020 |
| FY2018 | Dec 31, 2016 | $151.80B | Feb 21, 2019 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2015 | Dec 31, 2015 | $140.57B | Feb 11, 2016 |
| FY2015 | Dec 31, 2014 | $135.78B | Feb 11, 2016 |
| FY2015 | Dec 31, 2013 | $139.37B | Feb 11, 2016 |
| FY2014 | Dec 31, 2012 | $126.57B | Feb 13, 2015 |
| FY2013 | Dec 31, 2011 | $128.17B | Feb 18, 2014 |
| FY2012 | Dec 31, 2010 | $119.28B | Feb 19, 2013 |
| FY2011 | Dec 31, 2009 | $103.87B | Feb 21, 2012 |
| FY2010 | Dec 31, 2008 | $127.64B | Feb 28, 2011 |
| FY2009 | Dec 31, 2007 | $154.38B | Feb 25, 2010 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $5.88B | Feb 6, 2025 |
| FY2024 | Dec 31, 2023 | $4.35B | Feb 6, 2025 |
| FY2024 | Dec 31, 2022 | ($1.98B) | Feb 6, 2025 |
| FY2023 | Dec 31, 2021 | $17.94B | Feb 7, 2024 |
| FY2015 | Dec 31, 2015 | $1.87B | Feb 11, 2016 |
| FY2015 | Sep 30, 2015 | $2.19B | Feb 11, 2016 |
| FY2015 | Jun 30, 2015 | $2.16B | Feb 11, 2016 |
| FY2015 | Mar 31, 2015 | $1.15B | Feb 11, 2016 |
| FY2015 | Dec 31, 2014 | ($2.52B) | Feb 11, 2016 |
| FY2015 | Sep 30, 2014 | $1.02B | Feb 11, 2016 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($9.17B) | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $5.22B | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $5.46B | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $6.28B | Feb 6, 2025 |
| FY2023 | Dec 31, 2021 | $4.52B | Feb 7, 2024 |
| FY2022 | Dec 31, 2020 | ($4.41B) | Feb 3, 2023 |
| FY2021 | Dec 31, 2019 | $574.00M | Feb 4, 2022 |
| FY2020 | Dec 31, 2018 | $3.20B | Feb 5, 2021 |
| FY2019 | Dec 31, 2017 | $4.88B | Feb 5, 2020 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.40B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $8.00B | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $8.20B | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $7.80B | Feb 6, 2025 |
| FY2023 | Dec 31, 2021 | $7.60B | Feb 7, 2024 |
| FY2022 | Dec 31, 2020 | $7.10B | Feb 3, 2023 |
| FY2021 | Dec 31, 2019 | $7.40B | Feb 4, 2022 |
| FY2020 | Dec 31, 2018 | $8.20B | Feb 5, 2021 |
| FY2019 | Dec 31, 2017 | $8.00B | Feb 5, 2020 |
| FY2018 | Dec 31, 2016 | $7.30B | Feb 21, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.85B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $10.29B | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $10.70B | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $10.89B | Feb 6, 2025 |
| FY2023 | Dec 31, 2021 | $11.92B | Feb 7, 2024 |
| FY2022 | Dec 31, 2020 | $10.19B | Feb 3, 2023 |
| FY2021 | Dec 31, 2019 | $11.16B | Feb 4, 2022 |
| FY2020 | Dec 31, 2018 | $11.40B | Feb 5, 2021 |
| FY2019 | Dec 31, 2017 | $11.53B | Feb 5, 2020 |
| FY2018 | Dec 31, 2016 | $10.97B | Feb 21, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $21.28B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $15.42B | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $14.92B | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $6.85B | Feb 6, 2025 |
| FY2023 | Dec 31, 2021 | $15.79B | Feb 7, 2024 |
| FY2022 | Dec 31, 2020 | $24.27B | Feb 3, 2023 |
| FY2021 | Dec 31, 2019 | $17.64B | Feb 4, 2022 |
| FY2020 | Dec 31, 2018 | $15.02B | Feb 5, 2021 |
| FY2019 | Dec 31, 2017 | $18.10B | Feb 5, 2020 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $289.16B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $285.20B | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $273.31B | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $255.88B | Feb 6, 2025 |
| FY2023 | Dec 31, 2021 | $257.04B | Feb 7, 2024 |
| FY2022 | Dec 31, 2020 | $267.26B | Feb 3, 2023 |
| FY2021 | Dec 31, 2019 | $258.54B | Feb 4, 2022 |
| FY2020 | Dec 31, 2018 | $256.54B | Feb 5, 2021 |
| FY2019 | Dec 31, 2017 | $258.50B | Feb 5, 2020 |
| FY2018 | Dec 31, 2016 | $238.51B | Feb 21, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $253.18B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $240.34B | Feb 11, 2026 |
| FY2024 | Dec 31, 2023 | $230.51B | Feb 6, 2025 |
| FY2023 | Dec 31, 2022 | $212.72B | Feb 7, 2024 |
| FY2022 | Dec 31, 2021 | $208.41B | Feb 3, 2023 |
| FY2021 | Dec 31, 2020 | $236.45B | Feb 4, 2022 |
| FY2020 | Dec 31, 2019 | $225.31B | Feb 5, 2021 |
| FY2019 | Dec 31, 2018 | $220.47B | Feb 5, 2020 |
| FY2018 | Dec 31, 2017 | $222.79B | Feb 21, 2019 |
| FY2017 | Dec 31, 2016 | $208.67B | Feb 8, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $35.95B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $44.84B | Feb 11, 2026 |
| FY2024 | Dec 31, 2023 | $42.77B | Feb 6, 2025 |
| FY2024 | Dec 31, 2022 | $43.24B | Feb 6, 2025 |
| FY2024 | Dec 31, 2021 | $48.52B | Feb 6, 2025 |
| FY2023 | Dec 31, 2020 | $30.69B | Feb 7, 2024 |
| FY2020 | Dec 31, 2019 | $33.19B | Feb 5, 2021 |
| FY2019 | Dec 31, 2018 | $35.93B | Feb 5, 2020 |
| FY2018 | Dec 31, 2017 | $35.58B | Feb 21, 2019 |
| FY2017 | Dec 31, 2016 | $29.17B | Feb 8, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $483.00M | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $658.00M | Feb 11, 2026 |
| FY2024 | Dec 31, 2023 | $683.00M | Feb 6, 2025 |
| FY2023 | Dec 31, 2022 | $603.00M | Feb 7, 2024 |
| FY2022 | Dec 31, 2021 | $619.00M | Feb 3, 2023 |
| FY2021 | Dec 31, 2020 | $258.00M | Feb 4, 2022 |
| FY2020 | Dec 31, 2019 | $278.00M | Feb 5, 2021 |
| FY2019 | Dec 31, 2018 | $264.00M | Feb 5, 2020 |
| FY2018 | Dec 31, 2017 | $75.00M | Feb 21, 2019 |
| FY2017 | Dec 31, 2016 | $50.00M | Feb 8, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $22.51B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $33.74B | Feb 11, 2026 |
| FY2024 | Dec 31, 2023 | $31.03B | Feb 6, 2025 |
| FY2023 | Dec 31, 2022 | $31.75B | Feb 7, 2024 |
| FY2022 | Dec 31, 2021 | $35.77B | Feb 3, 2023 |
| FY2021 | Dec 31, 2020 | $18.24B | Feb 4, 2022 |
| FY2020 | Jan 1, 2020 | $20.12B | Feb 5, 2021 |
| FY2020 | Dec 31, 2019 | $20.32B | Feb 5, 2021 |
| FY2019 | Jan 1, 2019 | $22.68B | Feb 5, 2020 |
| FY2019 | Dec 31, 2018 | $22.67B | Feb 5, 2020 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $23.36B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $22.94B | Feb 11, 2026 |
| FY2024 | Dec 31, 2023 | $24.86B | Feb 6, 2025 |
| FY2023 | Dec 31, 2022 | $25.13B | Feb 7, 2024 |
| FY2022 | Dec 31, 2021 | $20.54B | Feb 3, 2023 |
| FY2021 | Dec 31, 2020 | $25.24B | Feb 4, 2022 |
| FY2020 | Dec 31, 2019 | $17.50B | Feb 5, 2021 |
| FY2019 | Dec 31, 2018 | $16.72B | Feb 5, 2020 |
| FY2018 | Dec 31, 2017 | $18.49B | Feb 21, 2019 |
| FY2017 | Dec 31, 2016 | $15.91B | Feb 8, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (2) | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | 1 | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 6, 2025 |
| FY2023 | Dec 31, 2021 | 4 | Feb 7, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Feb 3, 2023 |
| FY2021 | Dec 31, 2019 | 0 | Feb 4, 2022 |
| FY2020 | Dec 31, 2018 | 0 | Feb 5, 2021 |
| FY2019 | Dec 31, 2017 | 1 | Feb 5, 2020 |
| FY2018 | Dec 31, 2016 | 1 | Feb 21, 2019 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | (2) | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | 1 | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | 1 | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 6, 2025 |
| FY2023 | Dec 31, 2021 | 4 | Feb 7, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Feb 3, 2023 |
| FY2021 | Dec 31, 2019 | 0 | Feb 4, 2022 |
| FY2020 | Dec 31, 2018 | 0 | Feb 5, 2021 |
| FY2019 | Dec 31, 2017 | 1 | Feb 5, 2020 |
| FY2018 | Dec 31, 2016 | 1 | Feb 21, 2019 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.99B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $3.12B | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $5.00B | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $2.01B | Feb 6, 2025 |
| FY2023 | Dec 31, 2021 | $403.00M | Feb 7, 2024 |
| FY2022 | Dec 31, 2020 | $596.00M | Feb 3, 2023 |
| FY2021 | Dec 31, 2019 | $2.39B | Feb 4, 2022 |
| FY2020 | Dec 31, 2018 | $2.91B | Feb 5, 2021 |
| FY2019 | Dec 31, 2017 | $2.58B | Feb 5, 2020 |
| FY2018 | Dec 31, 2016 | $3.38B | Feb 21, 2019 |